IXHL (STOCKS)
Incannex Healthcare Limited American Depositary Shares
$3.670000
-0.160000 (-4.18%)
Prev close: $3.830000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joel Latham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,270.65M
- Employees
- 12
- P/E (TTM)
- -0.21
- P/B (TTM)
- 0.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-11.23 | $-0.94 | -10.2841 | -1,088.38% |
|
Sep 2025 (Q1)
|
$-0.60 | $-0.94 | +0.3449 | +36.50% |
|
Dec 2025 (Q2)
|
$-0.60 | $-0.94 | +0.3449 | +36.50% |
|
Jun 2025 (Q4)
|
$-15.30 | $-89.29 | +73.9911 | +82.87% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$23.05M |
| Operating Expenses | $25.36M |
| Depreciation and Amortization | $251.00K |
| Research and Development | $7.42M |
| Other Operating Expenses | $17.69M |
| Operating Income/Loss | -$25.36M |
| Income/Loss From Continuing Operations After Tax | -$48.41M |
| Income/Loss From Continuing Operations Before Tax | -$48.41M |
| Net Income/Loss | -$48.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$48.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$48.41M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $22.53 |
| Diluted Earnings Per Share | $22.53 |
| Basic Average Shares | 45,297,583 |
| Diluted Average Shares | 45,297,583 |
| Assets | $80.28M |
| Current Assets | $80.10M |
| Noncurrent Assets | $188.00K |
| Fixed Assets | $47.00K |
| Other Non-current Assets | $141.00K |
| Liabilities | $5.05M |
| Current Liabilities | $1.93M |
| Wages | $21.00K |
| Other Current Liabilities | $1.91M |
| Noncurrent Liabilities | $3.12M |
| Equity | $75.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $75.23M |
| Liabilities And Equity | $80.28M |
| Net Cash Flow From Operating Activities | -$17.72M |
| Net Cash Flow From Operating Activities, Continuing | -$17.72M |
| Net Cash Flow From Investing Activities | -$64.00K |
| Net Cash Flow From Investing Activities, Continuing | -$64.00K |
| Net Cash Flow From Financing Activities | $82.42M |
| Net Cash Flow From Financing Activities, Continuing | $82.42M |
| Exchange Gains/Losses | $3.11M |
| Net Cash Flow | $67.74M |
| Net Cash Flow, Continuing | $64.63M |
| Comprehensive Income/Loss | -$48.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$48.58M |
| Other Comprehensive Income/Loss | -$48.58M |